ATE269714T1 - Tcf-ii für vorbeugung und/oder behandlung von strahlungsinduzierter störungen - Google Patents
Tcf-ii für vorbeugung und/oder behandlung von strahlungsinduzierter störungenInfo
- Publication number
- ATE269714T1 ATE269714T1 AT98112761T AT98112761T ATE269714T1 AT E269714 T1 ATE269714 T1 AT E269714T1 AT 98112761 T AT98112761 T AT 98112761T AT 98112761 T AT98112761 T AT 98112761T AT E269714 T1 ATE269714 T1 AT E269714T1
- Authority
- AT
- Austria
- Prior art keywords
- tcf
- prevention
- radiation
- treatment
- induced disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9188384A JPH1129493A (ja) | 1997-07-14 | 1997-07-14 | 放射線障害予防及び／又は治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE269714T1 true ATE269714T1 (de) | 2004-07-15 |
Family
ID=16222690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98112761T ATE269714T1 (de) | 1997-07-14 | 1998-07-09 | Tcf-ii für vorbeugung und/oder behandlung von strahlungsinduzierter störungen |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5998370A (de) |
| EP (1) | EP0891778B1 (de) |
| JP (1) | JPH1129493A (de) |
| KR (1) | KR100564353B1 (de) |
| AT (1) | ATE269714T1 (de) |
| AU (1) | AU732053B2 (de) |
| CA (1) | CA2242559A1 (de) |
| DE (1) | DE69824670T2 (de) |
| DK (1) | DK0891778T3 (de) |
| ES (1) | ES2219810T3 (de) |
| ZA (1) | ZA986090B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1275718A3 (de) * | 1994-12-27 | 2003-03-19 | Daiichi Pharmaceutical Co., Ltd. | TCF Mutante |
| JP4006058B2 (ja) | 1997-03-11 | 2007-11-14 | 第一三共株式会社 | 多臓器不全予防及び／又は治療剤 |
| ATE344050T1 (de) | 1997-03-14 | 2006-11-15 | Daiichi Seiyaku Co | Verwendung von tcf-ii zur behandlung von durch krebs verursachtem gewichtsverlust, anaemie und tnf-erhöhung |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ232813A (en) * | 1989-03-10 | 1992-08-26 | Snow Brand Milk Products Co Ltd | Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons |
| KR100260964B1 (ko) * | 1992-07-16 | 2000-07-01 | 쇼노 카츄야 | Tcf-ii를 유효성분으로 하는 혈액응고 정상화제 |
| CA2100720C (en) * | 1992-07-16 | 2003-03-11 | Hiroaki Masunaga | Medicinal composition comprising tcf-ii |
| DE69310525T2 (de) * | 1992-09-16 | 1997-10-02 | Genentech Inc | Schutz gegen leberschäden mit hgf |
| JPH08176007A (ja) * | 1994-12-27 | 1996-07-09 | Snow Brand Milk Prod Co Ltd | 脂質代謝異常治療剤 |
| JP4006058B2 (ja) * | 1997-03-11 | 2007-11-14 | 第一三共株式会社 | 多臓器不全予防及び／又は治療剤 |
| ATE344050T1 (de) * | 1997-03-14 | 2006-11-15 | Daiichi Seiyaku Co | Verwendung von tcf-ii zur behandlung von durch krebs verursachtem gewichtsverlust, anaemie und tnf-erhöhung |
-
1997
- 1997-07-14 JP JP9188384A patent/JPH1129493A/ja active Pending
-
1998
- 1998-07-06 AU AU74174/98A patent/AU732053B2/en not_active Ceased
- 1998-07-07 CA CA002242559A patent/CA2242559A1/en not_active Abandoned
- 1998-07-08 KR KR1019980027414A patent/KR100564353B1/ko not_active IP Right Cessation
- 1998-07-09 ES ES98112761T patent/ES2219810T3/es not_active Expired - Lifetime
- 1998-07-09 DK DK98112761T patent/DK0891778T3/da active
- 1998-07-09 DE DE69824670T patent/DE69824670T2/de not_active Expired - Fee Related
- 1998-07-09 AT AT98112761T patent/ATE269714T1/de not_active IP Right Cessation
- 1998-07-09 ZA ZA986090A patent/ZA986090B/xx unknown
- 1998-07-09 EP EP98112761A patent/EP0891778B1/de not_active Expired - Lifetime
- 1998-07-14 US US09/115,294 patent/US5998370A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR19990013676A (ko) | 1999-02-25 |
| EP0891778A3 (de) | 2000-01-26 |
| CA2242559A1 (en) | 1999-01-14 |
| ES2219810T3 (es) | 2004-12-01 |
| DK0891778T3 (da) | 2004-08-09 |
| EP0891778A2 (de) | 1999-01-20 |
| DE69824670T2 (de) | 2004-12-09 |
| AU7417498A (en) | 1999-01-21 |
| DE69824670D1 (de) | 2004-07-29 |
| JPH1129493A (ja) | 1999-02-02 |
| US5998370A (en) | 1999-12-07 |
| EP0891778B1 (de) | 2004-06-23 |
| ZA986090B (en) | 1999-04-20 |
| KR100564353B1 (ko) | 2006-09-18 |
| AU732053B2 (en) | 2001-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE201138T1 (de) | Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose | |
| DE122009000012I1 (de) | Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen. | |
| DE69836752D1 (de) | Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen | |
| ATE231724T1 (de) | Kombinationstherapie für die behandlung von psychosen | |
| DE3579113D1 (de) | Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden. | |
| ATE411026T1 (de) | Mittel zur behandlung der alzheimer-krankheit | |
| DE69924375D1 (de) | Verwendung von optisch reinem (+)-norcisapride für die behandlung des reizdarmsyndroms | |
| DE60008143D1 (de) | Lipoxin-a4 und deren analoge zur behandlung von trockenen augen | |
| DE69526390D1 (de) | Kugelförmige Aktivkohle zur Behandlung von Stoma-peripherer Entzündung | |
| ATE226947T1 (de) | 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1- dioxiden, zusammensetzung und deren verwendung | |
| DE69532066D1 (de) | Arzneimittel zur Behandlung von Restenosis und Gefässsklerose | |
| DE69524623T2 (de) | Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen | |
| DE69710111T2 (de) | Behandlung und Prophylaxe von Pankreatitis | |
| BR9914848A (pt) | Composição e processo para o tratamento de distúrbios da retina externa | |
| EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
| ITMI920955A1 (it) | Idrogeli di tipo polietereammidoamminico come materiali eparinizzabili | |
| ATE269714T1 (de) | Tcf-ii für vorbeugung und/oder behandlung von strahlungsinduzierter störungen | |
| DE3582935D1 (de) | Mittel zur behandlung von erkrankungen der venen und des analbereichs. | |
| DE69526584D1 (de) | Verwendung von immunosuppressiva zur behandlung der schizophrenie | |
| DK1133296T3 (da) | Ny terapeutisk anvendelse af nicergolin | |
| RU97115054A (ru) | Средство для лечения онкологических больных | |
| ATA93695A (de) | Mittel zur behandlung von strahlenschäden | |
| BR9909868A (pt) | Ascorbato de paroxetina | |
| DE68908445T2 (de) | Mittel zur Behandlung von Lebererkrankungen. | |
| DE3585312D1 (de) | Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0891778 Country of ref document: EP |
|
| EEIH | Change in the person of patent owner | ||
| REN | Ceased due to non-payment of the annual fee |